Related Experiment Video
Updated: Apr 7, 2026
07:57
An Experimental Human DIEP Flap Model to Investigate Preservation Strategies for Vascularized Composite Allografts and Free Flaps
Published on: December 5, 2025
413
Abdominal perforator vs. muscle sparing flaps for breast reconstruction
1Division of Plastic Surgery, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.
Gland Surgery
|July 11, 2015
Summary
Free flaps for breast reconstruction offer aesthetic results using autologous tissue. This review compares muscle-sparing free transverse rectus abdominis myocutaneous (MsfTRAM), deep inferior epigastric artery perforator (DIEP), and superficial inferior epigastric artery (SIEA) flaps to optimize outcomes and minimize donor site morbidity.
Area of Science:
- Microsurgery
- Plastic Surgery
- Breast Reconstruction
Background:
- Abdominally based free flaps are standard for autologous breast reconstruction post-mastectomy.
- Technological advancements focus on reducing abdominal donor site morbidity while achieving aesthetic outcomes.
Purpose of the Study:
- To compare muscle-sparing free transverse rectus abdominis myocutaneous (MsfTRAM), deep inferior epigastric artery perforator (DIEP), and superficial inferior epigastric artery (SIEA) flaps.
- To evaluate flap success, operative times, donor site morbidity, hospital stay, costs, and resilience to radiation.
Main Methods:
- Comparative review of MsfTRAM, DIEP, and SIEA flap techniques.
- Analysis of outcomes including flap viability, aesthetic results, and patient-reported functionality.
Main Results:
- Data on flap success rates, operative duration, and hospital length of stay were analyzed.
- Abdominal donor site morbidity, functional recovery, and costs were compared across flap types.
- Resilience of reconstructions following adjuvant radiation therapy was assessed.
Conclusions:
- The study provides a comprehensive comparison of key autologous free flap options for breast reconstruction.
- Findings aim to guide surgical choices towards optimal patient outcomes and reduced donor site complications.
